The FDA Announces Two More Antacid Recalls Due to Cancer Risk – WIRED

Share this Story

Two more companies recalled their ranitidine drugs, generic forms of Zantac, over concerns they may contain a carcinogenic substance.

Author: Michele Cohen Marill

READ MORE